Why Badger Meter Stock Is Plummeting Today

Badger Meter reported first-quarter sales down 9% and EPS down 29%, both below Wall Street expectations, sending the stock down 19% intraday and leaving it 37% lower over the past year. Management said the decline was driven by project-timing gaps rather than weakening underlying demand, and expects sales to improve sequentially through 2026 with 2.6 million to 3.6 million future connections slated for deployment in the second half of 2026.

Analysis

The market is reacting to a near-term air pocket, but the more important signal is that BMI’s demand is still project-led rather than structurally impaired. That matters because lumpy utility deployments can create the illusion of a cyclical downshift right when the business is actually entering a replenishment phase; in this setup, the stock often overshoots on the downside before the backlog/installation cadence re-accelerates.

The second-order implication is competitive: if management is right that the issue is timing, then smaller metering vendors and pure-play installers may be the real near-term losers. A temporary spending pause tends to favor the incumbent with the strongest software/monitoring attach rate, because customers defer discretionary hardware but are less likely to rip out embedded systems once installed; that creates a sticky installed base effect that can reassert margins once deployments normalize.

From a risk standpoint, the main bearish case is not one bad quarter but a delayed 2H26 deployment window slipping into 2027, which would extend the revenue gap and pressure operating leverage for multiple quarters. Near-term, the stock can remain volatile until investors see sequential order improvement; over 3-6 months the key catalyst is whether management can prove the “flat-to-higher” revenue path with actual bookings, not commentary.

The setup looks like an overreaction relative to the duration of the impairment: a 19% one-day drawdown is pricing in a multi-year demand break, while the evidence points to a timing mismatch. If the market gains confidence in the 2026 project cycle, the multiple can re-rate quickly because FCF normalization would likely look much better than headline EPS suggests. The key is that this is a visibility problem, not obviously a terminal problem.

Key Decisions for Investors

• Buy BMI on weakness in staged tranches over the next 1-3 weeks; use a 6-12 month horizon and size for volatility, targeting a rebound as sequential revenue improves and the 2H26 project pipeline becomes visible. Risk/reward is attractive if the market is over-discounting a timing issue rather than a demand break.
• Sell downside puts on BMI (3-6 month tenor) only if implied volatility remains elevated after the gap-down; this monetizes panic while defining entry near a level where the valuation discount starts to compensate for execution risk.
• Pair trade: long BMI / short a basket of lower-quality utility capex proxies or other project-dependent industrial names with weaker recurring revenue characteristics. The thesis is that BMI’s installed base and software attach should recover faster than peers once timing normalizes.